Recent insights into the function of autophagy in cancer
- PMID: 27664235
- PMCID: PMC5066235
- DOI: 10.1101/gad.287524.116
Recent insights into the function of autophagy in cancer
Abstract
Macroautophagy (referred to here as autophagy) is induced by starvation to capture and degrade intracellular proteins and organelles in lysosomes, which recycles intracellular components to sustain metabolism and survival. Autophagy also plays a major homeostatic role in controlling protein and organelle quality and quantity. Dysfunctional autophagy contributes to many diseases. In cancer, autophagy can be neutral, tumor-suppressive, or tumor-promoting in different contexts. Large-scale genomic analysis of human cancers indicates that the loss or mutation of core autophagy genes is uncommon, whereas oncogenic events that activate autophagy and lysosomal biogenesis have been identified. Autophagic flux, however, is difficult to measure in human tumor samples, making functional assessment of autophagy problematic in a clinical setting. Autophagy impacts cellular metabolism, the proteome, and organelle numbers and quality, which alter cell functions in diverse ways. Moreover, autophagy influences the interaction between the tumor and the host by promoting stress adaptation and suppressing activation of innate and adaptive immune responses. Additionally, autophagy can promote a cross-talk between the tumor and the stroma, which can support tumor growth, particularly in a nutrient-limited microenvironment. Thus, the role of autophagy in cancer is determined by nutrient availability, microenvironment stress, and the presence of an immune system. Here we discuss recent developments in the role of autophagy in cancer, in particular how autophagy can promote cancer through suppressing p53 and preventing energy crisis, cell death, senescence, and an anti-tumor immune response.
Keywords: ATG; autophagy; cancer; chloroquine; mouse models.
© 2016 Amaravadi et al.; Published by Cold Spring Harbor Laboratory Press.
Similar articles
-
Autophagy, Metabolism, and Cancer.Clin Cancer Res. 2015 Nov 15;21(22):5037-46. doi: 10.1158/1078-0432.CCR-15-0490. Clin Cancer Res. 2015. PMID: 26567363 Free PMC article. Review.
-
Autophagy dysfunctions associated with cancer cells and their therapeutic implications.Biomed Pharmacother. 2019 Jul;115:108892. doi: 10.1016/j.biopha.2019.108892. Epub 2019 Apr 25. Biomed Pharmacother. 2019. PMID: 31029889 Review.
-
The role for autophagy in cancer.J Clin Invest. 2015 Jan;125(1):42-6. doi: 10.1172/JCI73941. Epub 2015 Jan 2. J Clin Invest. 2015. PMID: 25654549 Free PMC article. Review.
-
Autophagic tumor stroma: mechanisms and roles in tumor growth and progression.Int J Cancer. 2013 Jan 1;132(1):1-8. doi: 10.1002/ijc.27664. Epub 2012 Jun 26. Int J Cancer. 2013. PMID: 22684793 Review.
-
Here, there be dragons: charting autophagy-related alterations in human tumors.Clin Cancer Res. 2012 Mar 1;18(5):1214-26. doi: 10.1158/1078-0432.CCR-11-2465. Epub 2012 Jan 17. Clin Cancer Res. 2012. PMID: 22253413 Review.
Cited by
-
Non-apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages.J Cell Mol Med. 2024 Apr;28(8):e18348. doi: 10.1111/jcmm.18348. J Cell Mol Med. 2024. PMID: 38652105 Free PMC article. Review.
-
Selective degradation of PL2L60 by metabolic stresses‑induced autophagy suppresses multi‑cancer growth.Oncol Rep. 2024 Mar;51(3):41. doi: 10.3892/or.2024.8700. Epub 2024 Jan 12. Oncol Rep. 2024. PMID: 38624021 Free PMC article.
-
The Triple Adipose-Derived Stem Cell Exosome Technology as a Potential Tool for Treating Triple-Negative Breast Cancer.Cells. 2024 Apr 2;13(7):614. doi: 10.3390/cells13070614. Cells. 2024. PMID: 38607053 Free PMC article. Review.
-
A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines.Front Pharmacol. 2024 Mar 20;15:1340855. doi: 10.3389/fphar.2024.1340855. eCollection 2024. Front Pharmacol. 2024. PMID: 38572424 Free PMC article. Review.
-
Global research and emerging trends in autophagy in lung cancer: a bibliometric and visualized study from 2013 to 2022.Front Pharmacol. 2024 Feb 27;15:1352422. doi: 10.3389/fphar.2024.1352422. eCollection 2024. Front Pharmacol. 2024. PMID: 38476332 Free PMC article.
References
-
- Abe T, Toyota M, Suzuki H, Murai M, Akino K, Ueno M, Nojima M, Yawata A, Miyakawa H, Suga T, et al. 2005. Upregulation of BNIP3 by 5-aza-2′-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. J Gastroenterol 40: 504–510. - PubMed
-
- Aita VM, Liang XH, Murty VV, Pincus DL, Yu W, Cayanis E, Kalachikov S, Gilliam TC, Levine B. 1999. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59: 59–65. - PubMed
-
- Akada M, Crnogorac-Jurcevic T, Lattimore S, Mahon P, Lopes R, Sunamura M, Matsuno S, Lemoine NR. 2005. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer. Clin Cancer Res 11: 3094–3101. - PubMed
-
- Akalay I, Janji B, Hasmim M, Noman MZ, Andre F, De Cremoux P, Bertheau P, Badoual C, Vielh P, Larsen AK, et al. 2013. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res 73: 2418–2427. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 CA072720/CA/NCI NIH HHS/United States
- R01 CA193970/CA/NCI NIH HHS/United States
- P01 CA114046/CA/NCI NIH HHS/United States
- R01 CA198015/CA/NCI NIH HHS/United States
- R01 CA157490/CA/NCI NIH HHS/United States
- R01 GM095567/GM/NIGMS NIH HHS/United States
- P50 CA174523/CA/NCI NIH HHS/United States
- R01 CA163591/CA/NCI NIH HHS/United States
- R01 CA169134/CA/NCI NIH HHS/United States
- P30 CA016520/CA/NCI NIH HHS/United States
- R01 CA188048/CA/NCI NIH HHS/United States
- R01 CA130893/CA/NCI NIH HHS/United States
- R01 CA188096/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous